← Back to Trial

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Trial Locations

• Highlands Oncology Group Fayetteville, Arkansas, United States
  • Contact: Evan Hubbard · +1 479 878 7098 · [email protected] (opens in new tab)
• VA Greater LA Healthcare System Los Angeles, California, United States
  • Contact: Samantha Tran · 310-478-3711 · [email protected] (opens in new tab)
• VA Palo Alto Health Care System Palo Alto, California, United States
  • Contact: Niko Del Mar · 650-493-5000 · [email protected] (opens in new tab)
• Stanford University Palo Alto, California, United States
  • Contact: Camellia Djebroun · 605-498-6000 · [email protected] (opens in new tab)
• UCSF San Francisco, California, United States
  • Contact: Francim Aguilar · 415-514-6241 · [email protected] (opens in new tab)
• Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Contact: Jennifer Hege · 303-338-4876 · [email protected] (opens in new tab)
• Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Contact: Bhaloo Desai · [email protected] (opens in new tab)
• Woodlands Medical Specialists Pensacola, Florida, United States
  • Contact: Jacqueline Martin · [email protected] (opens in new tab)
• Piedmont Healthcare Atlanta, Georgia, United States
  • Contact: Sharon Joseph
• University of Chicago Chicago, Illinois, United States
  • Contact: Ashley Page · 773-702-8582 · [email protected] (opens in new tab)
• The Cancer Institute of Alexian Brothers Elk Grove, Illinois, United States
  • Contact: Khalada Ahmad · [email protected] (opens in new tab)
• Unity Point Clinic Des Moines, Iowa, United States
  • Contact: Missy Stravers · [email protected] (opens in new tab)
• University of Kansas Hospital Kansas City, Kansas, United States
  • Contact: Daniel Rivera · [email protected] (opens in new tab)
• Mary Bird Perkins Cancer Center Baton Rouge, Louisiana, United States
  • Contact: Courtney Hill · 225-215-1353 · [email protected] (opens in new tab)
• East Jefferson Hospital Metairie, Louisiana, United States
  • Contact: Alexandra Lieberman · [email protected] (opens in new tab)
• University of Maryland Medical Ctr Baltimore, Maryland, United States
  • Contact: Dawn Barth · 410-328-8667 · [email protected] (opens in new tab)
• Johns Hopkins Kimmel Com Cancer Ctr Baltimore, Maryland, United States
  • Contact: Dana Kaplan · [email protected] (opens in new tab)
• Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Contact: Sinead Christensen · [email protected] (opens in new tab)
• Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
  • Contact: Katerina von Helms · [email protected] (opens in new tab)
• BAMF Health Grand Rapids, Michigan, United States
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Profound Research LLC Royal Oak, Michigan, United States
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• William Beaumont Hospital Royal Oak, Michigan, United States
  • Contact: Jennifer Murray · 248-551-6485 · [email protected] (opens in new tab)
• Mayo Clinic Rochester Rochester, Minnesota, United States
  • Contact: Takeru Walleser · 507-538-2155 · [email protected] (opens in new tab)
• St Louis University St Louis, Missouri, United States
  • Contact: Sabrina Abdullaeva · [email protected] (opens in new tab)
• VA St Louis Health Care System St Louis, Missouri, United States
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Wash U School of Medicine St Louis, Missouri, United States
  • Contact: Collin Welch · [email protected] (opens in new tab)
• The Urology Center PC DBA UroHealth Partners Omaha, Nebraska, United States
  • Contact: Amy Nelson · [email protected] (opens in new tab)
• Memorial Sloan Kettering Cancer Ctr New York, New York, United States
  • Contact: Viktoria Matessi · 212-639-3854 · [email protected] (opens in new tab)
• Associated Med Professionals of NY Syracuse, New York, United States
  • Contact: Alex Bart · [email protected] (opens in new tab)
• Montefiore Hospital The Bronx, New York, United States
  • Contact: Darciann O Sullivan · 267-455-2717 · [email protected] (opens in new tab)
• East Carolina University Greenville, North Carolina, United States
  • Contact: Kaleigh Nunley · 252-744-0456 · [email protected] (opens in new tab)
• Dayton Physicians Kettering, Ohio, United States
  • Contact: Lynette Tipton · 937-771-2287 · [email protected] (opens in new tab)
• Oregon Urology Institute Springfield, Oregon, United States
  • Contact: Victoria Evans · 541-284-5508 · [email protected] (opens in new tab)
• Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
  • Contact: Rebecca Floyd · 843-839-1679 · [email protected] (opens in new tab)
• Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Contact: Laura Diedrich · [email protected] (opens in new tab)
• Univ of Texas Southwest Med Center Dallas, Texas, United States
  • Contact: Amy Rowell · 214-645-5905 · [email protected] (opens in new tab)
• Rio Grande Urology El Paso, Texas, United States
  • Contact: Paola Delgado · [email protected] (opens in new tab)
• Virginia Oncology Associates Norfolk, Virginia, United States
  • Contact: Amber Ingram · 757-466-8683 · [email protected] (opens in new tab)
• Blue Ridge Cancer Center Wytheville, Virginia, United States
  • Contact: Tessa Blair · [email protected] (opens in new tab)
• Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site CABA, Argentina
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Caba, Argentina
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Herston, Queensland, Australia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Adelaide, South Australia, Australia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Malvern, Victoria, Australia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Linz, Austria
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Vienna, Austria
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Aalst, Belgium
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Ghent, Belgium
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Wilrijk, Belgium
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site São Paulo, São Paulo, Brazil
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Calgary, Alberta, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Halifax, Nova Scotia, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site London, Ontario, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Ottawa, Ontario, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Toronto, Ontario, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Montreal, Quebec, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Montreal, Quebec, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Québec, Quebec, Canada
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Beijing, China
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Guangzhou, China
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Shanghai, China
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Bogota, Cundinamarca, Colombia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Bogotá, Colombia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Ostrava, Poruba, Czechia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Olomouc, Czechia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Prague, Czechia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Saint-Cloud, Hauts De Seine, France
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Bordeaux, France
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Bron, France
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Clermont-Ferrand, France
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Rouen, France
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Saint-Herblain, France
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Munich, Bavaria, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Cologne, North Rhine-Westphalia, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Aachen, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Augsburg, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Berlin, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Essen, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Münster, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Rostock, Germany
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Athens, Greece
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Thessaloniki, Greece
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Debrecen, Hajdu Bihar Megye, Hungary
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Budapest, Hungary
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Budapest, Hungary
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Beersheba, Israel
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Haifa, Israel
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Jerusalem, Israel
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Petah Tikva, Israel
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Tel Aviv, Israel
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Brescia, BS, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Cona, FE, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Genova, GE, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Milan, MI, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Rozzano, MI, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Pisa, PI, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Roma, RM, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Negrar, VR, Italy
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Kashiwa, Chiba, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Sapporo, Hokkaido, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Kobe, Hyōgo, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Yokohama, Kanagawa, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Chuo Ku, Tokyo, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Fukuoka, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Fukuoka, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Fukuoka, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Fukushima, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Ishikawa, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Kyoto, Japan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Petaling Jaya, Selangor, Malaysia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Kuala Lumpur, Malaysia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Mexico City, Mexico City, Mexico
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Huxquilucan, Mexico
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Amsterdam, Netherlands
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• VA Caribbean Healthcare System San Juan, Puerto Rico
  • Contact: Sara Fuentes-Medina · +17876417582#10393 · [email protected] (opens in new tab)
• Novartis Investigative Site Singapore, Singapore
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Singapore, Singapore
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Bratislava, Slovakia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Košice, Slovakia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Nitra, Slovakia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Trenčín, Slovakia
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Granada, Andalusia, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site L'Hospitalet de Llobregat, Barcelona, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Barcelona, Catalonia, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site El Palmar, Murcia, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Barcelona, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Madrid, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Madrid, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Seville, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Valencia, Spain
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Geneva, Switzerland
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Lucerne, Switzerland
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Zurich, Switzerland
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Taipei, Taiwan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Taipei, Taiwan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Taipei, Taiwan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Taoyuan, Taiwan
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Bristol, Avon, United Kingdom
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Guildford, Surrey, United Kingdom
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site Coventry, United Kingdom
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site London, United Kingdom
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)
• Novartis Investigative Site London, United Kingdom
  • Contact: Novartis Pharmaceuticals · 1-888-669-6682 · [email protected] (opens in new tab)